Trials / Unknown
UnknownNCT04841044
Health Effects of Cetoleic Acid (A Randomized Double Blinded Controlled Trial)
Health Effects of Cetoleic Acid (Helseeffekter av Ketolinsyre)
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- Sponsor
- University of Oslo · Academic / Other
- Sex
- All
- Age
- 20 Years – 70 Years
- Healthy volunteers
- Accepted
Summary
In this Randomized Controlled Trial (RCT) we want to study how supplements of cetoleic acid ( C22:n1-11) (intervention) affect the conversion of alpha-linolenic acid (ALA) to EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid) in healthy subjects, compared to supplements with a low concentration of cetoleic acid (control). Our primary endpoints are changes in the concentration of EPA and DHA in plasma and red blood cells.
Detailed description
This is a randomized double-blinded controlled trial ( randomized 1:1). Study population: healthy men and women 20-70 years, BMI 20-35 kg/m2. Study design: * 3 weeks run-in-period where all participants consume control capsules every morning. * Randomization intervention: control (1:1). All participants consume their capsules (control or intervention) for 4 weeks. The intervention oil consists of a fish oil high in cetoleic acid and the control oil is a mix of different oils and low in cetoleic acid. Power calculation and sample size: It was expected a difference of 15% in n-3 between the groups after the intervention (Østbye et al. 2019, doi:10.1017/S0007114519001478). The level of significance was set to 5% (two-sided) and the power to 80%. A total of thirty-eight subjects were required to participate in the study, but a high dropout rate was expected (20%) and it was considered necessary to include a total of seventy (n=70) subjects (thirty-five per arm).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Cetoleic acid | Very long monounsaturated fatty acid ( C22:1n-11) |
| DIETARY_SUPPLEMENT | Control Oil | Control oil consisting of: mix of anchovy oil, olive oil, high-oleic sunflower oil and rapeseed oil |
Timeline
- Start date
- 2021-04-27
- Primary completion
- 2022-04-30
- Completion
- 2025-12-31
- First posted
- 2021-04-12
- Last updated
- 2021-10-04
Locations
1 site across 1 country: Norway
Source: ClinicalTrials.gov record NCT04841044. Inclusion in this directory is not an endorsement.